A DFT study of Graphene as a drug carrier for gemcitabine anticancer drug

被引：1

作者：

Abahussain, Abdulaziz A. M. ^{[1
]}

Zaidi, S. Z. J. ^{[2
]}

Nazir, M. H. ^{[2
,3
]}

Raza, M. ^{[2
]}

Hassan, S. ^{[4
]}

机构：

[1] King Saud Univ, Dept Chem Engn, Riyadh, Saudi Arabia

[2] Univ Punjab, Inst Chem Engn & Technol, Lab Energy Water & Healthcare Technol, Lahore 54000, Punjab, Pakistan

[3] Univ South Wales, Fac Comp Engn & Sci, Caerleon, Wales

[4] Univ Hong Kong, Dept Mech Engn, Hong Kong, Peoples R China

来源：

JOURNAL OF NEW MATERIALS FOR ELECTROCHEMICAL SYSTEMS | 2022年 / 25卷 / 04期

关键词：

gemcitabine; graphene; density functional theory; drug delivery;

D O I：

10.14447/jnmes.v25i4.a02

中图分类号：

O646 [电化学、电解、磁化学];

学科分类号：

081704 ;

摘要：

Research is being carried out worldwide for possible treatment of cancer. Graphene has been studied as a drug carrier for various cancer-related drugs [1-2]. In the present work, we apply theoretical models to study the electrons interactions, thermodynamic properties, and solvent interaction of the drug-carrier configuration. The stability of graphene means that it can be a nanocarrier in the biological system. The simulations result shows that graphene provides a stable base, where gemcitabine is a highly dissolvable and reactive drug. The adsorption of gemcitabine on the graphene was physical. The drug carrier configuration formed a highly impactful drug-carrier design.

引用

页码：234 / 239

页数：6

共 50 条

[41] On the potential of the WSi12 superatom as a drug carrier: a DFT study
Liu, Bin
Zhang, Jia-Chen
Ye, Ya-Ling
Chen, Jing-Hua
Sun, Wei-Ming
PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2025, 27 (11) : 5710 - 5719
[42] ANTICANCER AGENT COUPLED TO POLYASPARTAMIDE AS A DRUG CARRIER
GIAMMONA, G
CARLISI, B
CAVALLARO, G
PITARRESI, G
PALAZZO, S
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1992, 38 (05) : 159 - 162
[43] Covalent organic framework as smart and high efficient carrier for anticancer drug delivery: a DFT calculations and molecular dynamics simulation study
Hashemzadeh, Hassan
Raissi, Heider
JOURNAL OF PHYSICS D-APPLIED PHYSICS, 2018, 51 (34)
[44] Theoretical Study of Interaction between Apalutamide Anticancer Drug and Thymine by DFT Method
Siyamak, Shahab
Masoome, Sheikhi
Mehrnoosh, Khaleghian
Shamsa, Sharifi
Sadegh, Kaviani
CHINESE JOURNAL OF STRUCTURAL CHEMISTRY, 2019, 38 (10) : 1645 - 1663
[45] Theoretical Study of Interaction between Apalutamide Anticancer Drug and Thymine by DFT Method
SIYAMAK Shahab
MASOOME Sheikhi
MEHRNOOSH Khaleghian
SHAMSA Sharifi
SADEGH Kaviani
Chinese Journal of Structural Chemistry, 2019, 38 (10) : 1645 - 1663
[46] The chemistry of dinuclear analogues of the anticancer drug cisplatin. A DFT/CDM study
Deubel, DV
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (05) : 1654 - 1663
[47] Pristine B40 fullerene as a potential gemcitabine drug carrier for anti-lung cancer properties: a DFT and QTAIM study
Sukumar, Abisha Nancy
Duraisamy, Parimala Devi
Paul, Prince Makarios
Gopalan, Praveena
Angamuthu, Abiram
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024,
[48] In vitro genotoxic effects of the anticancer drug gemcitabine in human lymphocytes
Aydemir, N
Çelikler, S
Bilaloglu, R
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2005, 582 (1-2) : 35 - 41
[49] Circadian physiology is a toxicity target of the anticancer drug gemcitabine in mice
Li, X. M.
Levi, F.
JOURNAL OF BIOLOGICAL RHYTHMS, 2007, 22 (02) : 159 - 166
[50] Functionalized Graphene Platforms for Anticancer Drug Delivery
Sattari, Shabnam
Adeli, Mohsen
Beyranvand, Siamak
Nemati, Mohammad
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2021, 16 : 5955 - 5980

← 1 2 3 4 5 →